Biltmore Family Office LLC Sells 526 Shares of SPDR S&P Biotech ETF $XBI

Biltmore Family Office LLC lowered its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 16,899 shares of the exchange traded fund’s stock after selling 526 shares during the quarter. Biltmore Family Office LLC’s holdings in SPDR S&P Biotech ETF were worth $1,401,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Golden State Wealth Management LLC raised its holdings in shares of SPDR S&P Biotech ETF by 100.0% during the 1st quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock valued at $52,000 after buying an additional 319 shares in the last quarter. Perigon Wealth Management LLC raised its holdings in shares of SPDR S&P Biotech ETF by 6.7% during the 1st quarter. Perigon Wealth Management LLC now owns 4,810 shares of the exchange traded fund’s stock valued at $390,000 after buying an additional 300 shares in the last quarter. Essex Financial Services Inc. purchased a new position in shares of SPDR S&P Biotech ETF during the 1st quarter valued at about $208,000. Vontobel Holding Ltd. raised its holdings in shares of SPDR S&P Biotech ETF by 204.0% during the 1st quarter. Vontobel Holding Ltd. now owns 20,954 shares of the exchange traded fund’s stock valued at $1,699,000 after buying an additional 14,061 shares in the last quarter. Finally, Summit Trail Advisors LLC raised its holdings in shares of SPDR S&P Biotech ETF by 30.0% during the 1st quarter. Summit Trail Advisors LLC now owns 12,737 shares of the exchange traded fund’s stock valued at $1,033,000 after buying an additional 2,941 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 0.4%

Shares of NYSEARCA XBI opened at $112.00 on Wednesday. The stock has a market cap of $6.87 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 1-year low of $66.66 and a 1-year high of $112.43. The stock’s 50-day moving average is $98.97 and its 200 day moving average is $88.51.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.